Home › Steatotic Liver Disease › Florida › Brandon
Steatotic Liver Disease clinical trials in Brandon, FL
4 studies for Steatotic Liver Disease are looking for participants at sites in and around Brandon (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Covenant Metabolic Specialists - Riverview, Riverview · 6 mi away
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Brandon
- Akero Clinical Study Site, Riverview · 6 mi away
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Brandon
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RecruitingPhase 2
- GSK Investigational Site, Brandon
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- Hialeah, FL9 studies
- Orlando, FL9 studies
- St. Louis, MO9 studies
Other studies in Brandon
- Major Depressive Disorder6 studies
- Disorders of Excessive Somnolence6 studies
- High Blood Pressure5 studies
- Sleep Disorders5 studies
- Lupus4 studies
- Narcolepsy4 studies
- Idiopathic Hypersomnia4 studies
- COPD3 studies
- Heart Failure3 studies
- Depression3 studies
- Chronic Kidney Disease3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.